These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1633628)

  • 1. NACB 15th annual symposium: Advances in clinical laboratory evaluation of cartilage, bone, and systemic rheumatic diseases. Washington, DC, July 26-27, 1991.
    Clin Biochem; 1992 Jun; 25(3):153-234. PubMed ID: 1633628
    [No Abstract]   [Full Text] [Related]  

  • 2. [Mechanisms of destruction and atrophy of the cartilage and bone from the point of view of a rheumatologist].
    Havelka S
    Revmatologiia (Mosk); 1989; (3):47-51. PubMed ID: 2609059
    [No Abstract]   [Full Text] [Related]  

  • 3. 15th annual UCLA symposium. Abstracts: Development and diseases of cartilage and bone matrix.
    J Cell Biochem Suppl; 1986; 10B():99-120. PubMed ID: 3457221
    [No Abstract]   [Full Text] [Related]  

  • 4. Runx2 and microRNA regulation in bone and cartilage diseases.
    Zhao W; Zhang S; Wang B; Huang J; Lu WW; Chen D
    Ann N Y Acad Sci; 2016 Nov; 1383(1):80-87. PubMed ID: 27526290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recent advances in epigenetic regulation of skeletal development, homeostasis and disease.
    McAlinden A
    Connect Tissue Res; 2017 Jan; 58(1):1. PubMed ID: 27813659
    [No Abstract]   [Full Text] [Related]  

  • 6. [Calcipenic osteopathies from the viewpoint of the rheumatologist].
    Bartelheimer H
    Z Rheumaforsch; 1972; 31(9):321-4. PubMed ID: 4540030
    [No Abstract]   [Full Text] [Related]  

  • 7. [Biochemistry of collagen and locomotor apparatus. Hereditary diseases of the connective tissue and rheumatic diseases (3)].
    Peyron JG
    Rev Rhum Mal Osteoartic; 1977 Mar; 44(3):199-205. PubMed ID: 191905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Morphological and biochemical study of growth cartilage in osteochondrodysplasias].
    Stanescu V; Stanescu R; Maroteaux P
    Arch Fr Pediatr; 1977 Mar; 34 Suppl 1():I-LXXX. PubMed ID: 70194
    [No Abstract]   [Full Text] [Related]  

  • 9. [Semaphorins as treatment targets for cartilage and bone damage caused by rheumatoid arthritis].
    Yoshida Y; Kumanogoh A
    Clin Calcium; 2015 Dec; 25(12):1795-800. PubMed ID: 26608854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary Cilia and Intraflagellar Transport Proteins in Bone and Cartilage.
    Yuan X; Yang S
    J Dent Res; 2016 Nov; 95(12):1341-1349. PubMed ID: 27250654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The connective tissue disorders: the mucopolysaccharidoeses. A review.
    Rodríguez G
    Bol Asoc Med P R; 1968 Mar; 60(3):124-8. PubMed ID: 4247374
    [No Abstract]   [Full Text] [Related]  

  • 12. [Connective tissue metabolites in tissue fluids. New possibilities for monitoring the fibrotic process].
    Bentsen KD; Hørslev-Petersen K; Junker P
    Ugeskr Laeger; 1986 Aug; 148(32):2007-11. PubMed ID: 3529559
    [No Abstract]   [Full Text] [Related]  

  • 13. Cytokine imbalance in non-immunological chronic disease.
    Müller B
    Cytokine; 2002 Jun; 18(6):334-9. PubMed ID: 12160522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Xerography in rheumatology and orthopedy (author's transl)].
    Jeanmart L; Decker A; Osteaux M; Baleriaux D; De Wilde A
    J Belge Rhumatol Med Phys; 1976; 31(1):5-12. PubMed ID: 1087307
    [No Abstract]   [Full Text] [Related]  

  • 15. The Wnt signaling pathway and bone metabolism.
    Johnson ML; Kamel MA
    Curr Opin Rheumatol; 2007 Jul; 19(4):376-82. PubMed ID: 17551370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Concept for a classification of the diseases of the locomotor system].
    Verh Dtsch Ges Rheumatol; 1974; 3(0):193-221. PubMed ID: 4546049
    [No Abstract]   [Full Text] [Related]  

  • 17. [A rare case of systemic cartilage disease; polychondritis chronica atrophicans probabiliter rheumatica].
    BOBER S; CZARNIECKI W
    Pol Arch Med Wewn; 1955; 25(1):69-80. PubMed ID: 14394902
    [No Abstract]   [Full Text] [Related]  

  • 18. [Symposium: Etiology of rheumatic diseases. 6. From the standpoint of metabolism of the connecting tissue--with special reference to intercellular matrix-composing proteoglycans].
    Murata K
    Ryumachi; 1973 Oct; 13(4):359-62. PubMed ID: 4278918
    [No Abstract]   [Full Text] [Related]  

  • 19. [Rheumatic diseases with skin manifestations: connective tissue metabolism and immune mechanisms (basic research and clinical aspects). Vienna, 26-28 April 1984. Symposium].
    Z Rheumatol; 1984; 43 Suppl 1():1-55. PubMed ID: 6335330
    [No Abstract]   [Full Text] [Related]  

  • 20. [Proteoglycan catabolism in inflammatory rheumatic disease, as correlated with histopathologic and ultrastructural modifications of articular cartilage].
    Ciobanu A; Ciobanu IR; Caloianu M; Moldovan L; Oancea A; Hălălău F; Laky D; Dinulescu I; Stănculescu M
    Rom J Morphol Embryol; 1993; 39(1-2):59-66. PubMed ID: 8032023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.